Ceftazidime for Injection USP and Dextrose for Injection USP, 2 g, 50 mL Duplex Container, RX only, B Braun Medical Inc., Bethlehem, PA 18018-3524, NDC 0264-3145-11

FDA recall notice · announced May 6, 2020 · B. Braun Medical

Class I FDA/FSIS Class I: reasonable probability that use will cause serious adverse health consequences or death.

The product

Ceftazidime for Injection USP and Dextrose for Injection USP, 2 g, 50 mL Duplex Container, RX only, B Braun Medical Inc., Bethlehem, PA 18018-3524, NDC 0264-3145-11

Reason for recall

Failed Stability Specifications: Out-of-Specification (OOS) results for High Molecular Weight Polymers.

Notes

Distribution: Product was distributed nationwide within the United States.
Lot/code information: Lot #: H8J812, Exp. Date 31 JUL 2020
Quantity: 22,488 Duplex containers
Status: Terminated
Products in this recall event:
- Ceftazidime for Injection USP and Dextrose for Injection USP, 2 g, 50 mL Duplex Container, RX only, B Braun Medical Inc., Bethlehem, PA 18018-3524, NDC 0264-3145-11 (D-1257-2020)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.